Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use SYNTHROID safely and effectively. See full prescribing information for SYNTHROID. SYNTHROID® (levothyroxine sodium) tablets, for oral use Initial U.S. Approval: 2002
Medication labelWhy this: Advisory · dailymed-prescription
Hypothyroidism SYNTHROID is indicated in adult and pediatric patients, including neonates, as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid -Stimulating Hormone, TSH) Suppression SYNTHROID is indicated in adult and pediatric patients, including neonates, as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. Limitations of Use SYNTHROID is not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with SYNTHROID may induce hyperthyroidism [see Warnings and Precautions ( 5.1 )]. SYNTHROID is not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis.
- generic_name
- levothyroxine sodium
- product_names
- Levothyroxine Sodium
- ndc
- 0074-4341, 0074-4341-13, 0074-4341-90, 0074-4341-19, 0074-4341-72, 0074-4552, 0074-4552-13, 0074-4552-90, 0074-4552-19, 0074-4552-11, 0074-4552-71, 0074-4552-72, 0074-5182, 0074-5182-13, 0074-5182-90, 0074-5182-71, 0074-5182-19, 0074-5182-11, 0074-5182-72, 0074-6594, 0074-6594-13, 0074-6594-90, 0074-6594-71, 0074-6594-19, 0074-6594-72, 0074-6624, 0074-6624-13, 0074-6624-90, 0074-6624-19, 0074-6624-11, 0074-6624-71, 0074-6624-72, 0074-9296, 0074-9296-13, 0074-9296-90, 0074-9296-19, 0074-9296-71, 0074-9296-72, 0074-7068, 0074-7068-13, 0074-7068-90, 0074-7068-71, 0074-7068-19, 0074-7068-11, 0074-7068-72, 0074-3727, 0074-3727-13, 0074-3727-90, 0074-3727-71, 0074-3727-19, 0074-3727-72, 0074-7069, 0074-7069-90, 0074-7069-71, 0074-7069-19, 0074-7069-11, 0074-7069-72, 0074-7070, 0074-7070-13, 0074-7070-90, 0074-7070-71, 0074-7070-19, 0074-7070-72, 0074-7148, 0074-7148-90, 0074-7148-19, 0074-7148-71, 0074-7148-11, 0074-7148-72, 0074-7149, 0074-7149-90, 0074-7149-19
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en